The FTC sued Hims & Hers alleging the telehealth company violated privacy commitments and engaged in deceptive billing practices. Regulators say Hims shared sensitive consumer health data with advertising partners such as Meta and Snap without appropriate consent, while also misleading customers about subscription and cancellation terms. The complaint alleges that consumers were charged and subscribed soon after intake forms rather than after meaningful provider consultation, despite marketing claims that customers would connect with a clinician to determine whether medication was appropriate. The enforcement action underscores a growing regulatory focus on how digital health companies manage data flows and consumer disclosures—issues that can directly affect commercial models for DTC biotech-adjacent services.